These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 18712996)
1. The role of biomimetism in developing nanostructured inorganic matrices for drug delivery. Roveri N; Palazzo B; Iafisco M Expert Opin Drug Deliv; 2008 Aug; 5(8):861-77. PubMed ID: 18712996 [TBL] [Abstract][Full Text] [Related]
3. Biomimetically grown apatite spheres from aggregated bioglass nanoparticles with ultrahigh porosity and surface area imply potential drug delivery and cell engineering applications. El-Fiqi A; Buitrago JO; Yang SH; Kim HW Acta Biomater; 2017 Sep; 60():38-49. PubMed ID: 28754647 [TBL] [Abstract][Full Text] [Related]
4. Nanostructured materials for applications in drug delivery and tissue engineering. Goldberg M; Langer R; Jia X J Biomater Sci Polym Ed; 2007; 18(3):241-68. PubMed ID: 17471764 [TBL] [Abstract][Full Text] [Related]
5. Applications of biomimetic systems in drug delivery. Venkatesh S; Byrne ME; Peppas NA; Hilt JZ Expert Opin Drug Deliv; 2005 Nov; 2(6):1085-96. PubMed ID: 16296811 [TBL] [Abstract][Full Text] [Related]
6. Nanostructured porous silicon-polymer-based hybrids: from biosensing to drug delivery. Bonanno LM; Segal E Nanomedicine (Lond); 2011 Dec; 6(10):1755-70. PubMed ID: 22122584 [TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of biomimetic nanoparticles for drug delivery. Carmona-Ribeiro AM Methods Mol Biol; 2012; 906():283-94. PubMed ID: 22791441 [TBL] [Abstract][Full Text] [Related]
11. Drug delivery from ordered mesoporous matrices. Manzano M; Colilla M; Vallet-Regí M Expert Opin Drug Deliv; 2009 Dec; 6(12):1383-400. PubMed ID: 19941412 [TBL] [Abstract][Full Text] [Related]
13. Prevention of microbial biofilms - the contribution of micro and nanostructured materials. Grumezescu AM; Chifiriuc CM Curr Med Chem; 2014; 21(29):3311. PubMed ID: 24606506 [TBL] [Abstract][Full Text] [Related]
14. Nanostructured materials based on mesoporous silica and mesoporous silica/apatite as osteogenic growth peptide carriers. Mendes LS; Saska S; Martines MA; Marchetto R Mater Sci Eng C Mater Biol Appl; 2013 Oct; 33(7):4427-34. PubMed ID: 23910362 [TBL] [Abstract][Full Text] [Related]
15. Interaction between a bisphosphonate, tiludronate and nanocrystalline apatite: in vitro viability and proliferation of HOP and HBMSC cells. Pascaud P; Bareille R; Bourget C; Amédée J; Rey C; Sarda S Biomed Mater; 2012 Oct; 7(5):054108. PubMed ID: 22972389 [TBL] [Abstract][Full Text] [Related]
16. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures. Chen Y; Chen H; Shi J Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014 [TBL] [Abstract][Full Text] [Related]
17. Bioinspired synthesis of multifunctional inorganic and bio-organic hybrid materials. Andre R; Tahir MN; Natalio F; Tremel W FEBS J; 2012 May; 279(10):1737-49. PubMed ID: 22510103 [TBL] [Abstract][Full Text] [Related]
18. Counteranion-directed, biomimetic control of silica nanostructures on surfaces inspired by biosilicification found in diatoms. Yang SH; Park JH; Cho WK; Lee HS; Choi IS Small; 2009 Sep; 5(17):1947-51. PubMed ID: 19544316 [No Abstract] [Full Text] [Related]
19. Advanced drug delivery nanosystems: perspectives and regulatory issues. Demetzos C Adv Exp Med Biol; 2015; 822():195-8. PubMed ID: 25416990 [TBL] [Abstract][Full Text] [Related]
20. Tailored synthetic polyamines for controlled biomimetic silica formation. Bernecker A; Wieneke R; Riedel R; Seibt M; Geyer A; Steinem C J Am Chem Soc; 2010 Jan; 132(3):1023-31. PubMed ID: 20041715 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]